US Patent Issued to GUANGZHOU REFORGENE MEDICINE, ZHEJIANG SYNSORBIO TECHNOLOGY on Dec. 16 for "Cas effector proteins, gene editing systems, and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,603, issued on Dec. 16, was assigned to GUANGZHOU REFORGENE MEDICINE Co. LTD. (Guangzhou, China) and ZHEJIANG SYNSORBIO TECHNOLOGY Co. LTD. (Shaoxing, China).

"Cas effector proteins, gene editing systems, and uses thereof" was invented by Junbin Liang (Guangzhou, China), Liancheng Huang (Guangzhou, China), Hui Xu (Guangzhou, China), Yang Sun (Shaoxing, China), Zhiqin Peng (Guangzhou, China), Kaiwei Si (Guangzhou, China) and Desheng Huangfu (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a novel Cas effector protein, a gene editing system, and uses thereof. The Cas effector protein is CasRfg.3 and similar proteins. The C...